Press + Publications

Two new managing directors at AMW GmbH in Warngau

Wilfried Fischer, founding partner of AMW GmbH in Warngau, has resigned from the management, but remains associated with the company as an important shareholder. His responsibilities will be taken over by the previous co-managing directors Friedrich Tegel and Philipp Karbach.

read more

Brussels, 21 December 2017: Investment Plan for Europe: EIB lends to AMW GmbH in Warngau

The European Investment Bank (EIB) is providing EUR 25 million to AMW GmbH (AMW). AMW is a specialist pharmaceutical company that specializes in novel drug delivery systems. With the money, AMW will be able to expand the development of innovative medicines, carry out clinical trials and expand its production capacity at its plant in Warngau in Upper Bavaria as well as at its subsidiary Endomedica (Halle, Saxony-Anhalt). A new building for research, development and production with special manufacturing technology and state-of-the-art laboratory equipment is to be built at the company headquarters in Warngau.

read more

On 22 June 2017, the AMW received a high visit from the Bavarian Minister of Economic Affairs and Deputy Prime Minister of the Free State of Bavaria.

Within this framework, the pharmaceutical plant was able to present itself as the largest training company in Warngau.

read more

A company that goes under the skin

Unnoticed by a larger public, a pharmaceutical company has established itself in the Warngau industrial estate of Birkerfeld.

read more

Patches instead of tablets

So far, most drugs are swallowed. But there has also been talk in the pharmaceutical industry that many medicines can be transported into the body more easily and gently via skin patches – and require much less active ingredient.

read more

SHS and KfW join Warngau pharmaceutical plants

SHS and KfW are participating in a capital increase in the Warngau (AMW) pharmaceutical plants.

read more